Arcadia Biosciences (RKDA) Revenue (2014 - 2026)

Arcadia Biosciences (RKDA) has reported Revenue for 13 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue fell 0.82% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $5.1 million (down 5.68% YoY), and the FY2025 full-year result was $4.9 million, down 3.71% from the prior year.
• Revenue climbed to $1.4 million in Q2 2026 per RKDA's latest filing, from $901000.0 in the prior quarter.
• Across five years, Revenue topped out at $3.9 million in Q2 2022 and bottomed at $744000.0 in Q4 2022.
• Historically, Revenue has averaged $1.5 million across 5 years, with a median of $1.3 million in 2023.
• The widest YoY moves for Revenue: up 288.89% in 2022, down 99.54% in 2022.
• Over 5 years, Revenue stood at $744000.0 in 2022, then increased by 4.44% to $777000.0 in 2023, then soared by 56.5% to $1.2 million in 2024, then retreated by 25.9% to $901000.0 in 2025, then soared by 60.16% to $1.4 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.4 million, $901000.0, and $1.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.